Real world treatment sequences and outcomes for metastatic renal cell carcinoma.

Real world treatment sequences and outcomes for metastatic renal cell carcinoma.

Show other versions (1)

<h4>Objectives</h4>The treatment landscape for metastatic renal cell carcinoma changed a lot in the last few years. This study aimed to assess the treatment sequences and outcomes for metastatic renal cell carcinoma in a real-world setting.<h4>Materials and methods</h4>We enr...

Full description

Bibliographic Details
Main Authors:	Gu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, Chun-Kuang Yang, Chia-Yen Lin, Sheng-Chun Hung, Kun-Yuan Chiu, Shun-Fa Yang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0294039&type=printable

Similar Items

Real world treatment sequences and outcomes for metastatic renal cell carcinoma
by: Gu-Shun Lai, et al.
Published: (2023-01-01)

Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.
by: Gu-Shun Lai, et al.
Published: (2024-01-01)

Renal volume matters: Assessing the association between excisional volume loss and renal function after partial nephrectomy
by: Gu-Shun Lai, et al.
Published: (2020-01-01)

Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer
by: Li-Yu Yang, et al.
Published: (2024-03-01)

Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
by: Li-Wen Chang, et al.
Published: (2021-01-01)

Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
by: Ju-Chuan Hu, et al.
Published: (2020-08-01)

Associations between LncRNA <i>MALAT1</i> Polymorphisms and Lymph Node Metastasis in Prostate Cancer
by: Ju-Chuan Hu, et al.
Published: (2021-09-01)

Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma
by: Chia-Yen Lin, et al.
Published: (2018-03-01)

Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy
by: Li-Wen Chang, et al.
Published: (2023-03-01)

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
by: Jian-Ri Li, et al.
Published: (2017-11-01)

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
by: Chuan-Shu Chen, et al.
Published: (2020-04-01)

Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
by: Shian-Shiang Wang, et al.
Published: (2013-01-01)

Auto-recruit path for bone health screening of outpatient management system for patient with prostate cancer initiating androgen deprivation therapy
by: Chia-yen Lin, et al.
Published: (2023-12-01)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
by: Hsiang-Chen Hsieh, et al.
Published: (2022-01-01)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy
by: Hsiang-Chen Hsieh, et al.
Published: (2022-01-01)

Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.
by: Jian-Ri Li, et al.
Published: (2022-01-01)

The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy
by: Li-Hua Huang, et al.
Published: (2024-02-01)

Blockade of the N-Methyl-D-Aspartate Glutamate Receptor Ameliorates Lipopolysaccharide-Induced Renal Insufficiency.
by: Chian-Shiung Lin, et al.
Published: (2015-01-01)

Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting.
by: Hsu-Heng Yen, et al.
Published: (2020-01-01)

Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study.
by: Wei-Cheng Chen, et al.
Published: (2023-01-01)

Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study
by: Wei-Cheng Chen, et al.
Published: (2023-01-01)

Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia.
by: Cheng-En Mei, et al.
Published: (2022-01-01)

Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics
by: Wei-Chun Weng, et al.
Published: (2020-04-01)

Primary renal angiosarcoma mimicking urothelial carcinoma – A case report and literature reviews
by: Che-Wei Chang, et al.
Published: (2021-01-01)

Association of SDF-1 and its receptor CXCR4 polymorphisms on the susceptibility of diabetic retinopathy in the Taiwanese population
by: Shu-Yen Peng, et al.
Published: (2023-11-01)

Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use
by: Cheng-Kuang Yang, et al.
Published: (2023-04-01)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
by: I-Jen Chiu, et al.
Published: (2020-03-01)

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
by: Yung-Yeh Su, et al.
Published: (2023-02-01)

Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
by: Yung-Luen Yu, et al.
Published: (2014-01-01)

Gefitinib as First-line Therapy for Advanced or Metastatic Non-small Cell Lung Cancer Patients in Southern Taiwan
by: Cheng-Ta Yang, et al.
Published: (2010-01-01)

Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
by: Tsung-Hsien Chiang, et al.
Published: (2022-02-01)

Radium-223 for metastatic, castration-resistant prostate cancer: A retrospective chart review study of real-world use in a tertiary hospital in Taiwan
by: Wei-Chun Weng, et al.
Published: (2022-10-01)

Association of angiopoietin-2 with renal outcome in chronic kidney disease.
by: Yi-Chun Tsai, et al.
Published: (2014-01-01)

Increased probability of mood disorders after age-related macular degeneration: a population-based cohort study
by: Chia-Yi Lee, et al.
Published: (2022-09-01)

Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study
by: Wen-Chien Cheng, et al.
Published: (2023-01-01)

Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population
by: Shou-Wu Lee, et al.
Published: (2022-03-01)

Anterior Uveitis Secondary to Avelumab and Pembrolizumab in a Patient with Metastatic Renal Cell Carcinoma—A Case Report
by: Wei-Lun Chu, et al.
Published: (2024-03-01)

Is fluid overload more important than diabetes in renal progression in late chronic kidney disease?
by: Yi-Chun Tsai, et al.
Published: (2013-01-01)

QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon
by: Wu-Wei Lai, et al.
Published: (2021-12-01)

The Association between Iron-Deficiency Anemia (IDA) and Septic Arthritis (SA): The Real-World Data
by: Cheng-Hung Chiang, et al.
Published: (2022-04-01)